MaxLinear, Inc. Announces Fourth Quarter and Fiscal Year 2025 Financial Results

Carbonatix Pre-Player Loader

Audio By Carbonatix

CARLSBAD, Calif.--(BUSINESS WIRE)--Jan 29, 2026--

MaxLinear, Inc. (Nasdaq: MXL), a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits, today announced financial results for the fourth quarter and fiscal year ended December 31, 2025.

Fourth Quarter Financial Highlights

GAAP basis:

  • Net revenue was $136.4 million, up 8% sequentially and up 48% from the year-ago quarter.
  • GAAP gross margin was 57.6%, compared to 56.9% in the prior quarter, and 55.6% in the year-ago quarter.
  • GAAP operating expenses were $93.4 million in the fourth quarter, or 68% of net revenue, compared to $113.2 million in the prior quarter, or 90% of net revenue, and $92.4 million in the year-ago quarter, or 100% of net revenue.
  • GAAP loss from operations was 11% of net revenue, compared to loss from operations of 33% of net revenue in the prior quarter, and loss from operations of 45% of net revenue in the year-ago quarter.
  • Net cash flow provided by operating activities was $10.4 million, compared to net cash flow provided by operating activities of $10.1 million in the prior quarter, and net cash flow used in operating activities of $27.8 million in the year-ago quarter.
  • GAAP diluted loss per share was $0.17, compared to diluted loss per share of $0.52 in the prior quarter, and diluted loss per share of $0.68 in the year-ago quarter.

Non-GAAP basis:

  • Non-GAAP gross margin was 59.6%, compared to 59.1% in the prior quarter, and 59.1% in the year-ago quarter.
  • Non-GAAP operating expenses were $59.2 million, or 43% of net revenue, compared to $59.5 million or 47% of net revenue in the prior quarter, and $61.3 million or 67% of net revenue in the year-ago quarter.
  • Non-GAAP income from operations was 16% of net revenue, compared to income of 12% in the prior quarter, and loss of 7% in the year-ago quarter.
  • Non-GAAP diluted earnings per share was $0.19, compared to earnings per share of $0.14 in the prior quarter, and loss per share of $0.09 in the year-ago quarter.

Fiscal Year 2025 Financial Highlights

  • Net revenue was $467.6 million, up 30% over fiscal year 2024.
  • GAAP gross margin was 56.8%, up from 54.0% in the prior year, and non-GAAP gross margin was 59.3%, down from 59.7% the prior year.
  • GAAP operating expenses were $392.7 million, or 84% of net revenue, compared to $418.1 million or 116% of net revenue in fiscal 2024, and non-GAAP operating expenses were $233.7 million, or 50% of net revenue, compared to $283.7 million or 79% of net revenue in the prior year.
  • GAAP loss from operations was 27% of net revenue, compared to GAAP loss from operations of 62% in fiscal 2024, and non-GAAP income from operations was 9% of net revenue, compared to non-GAAP loss from operations of 19% in the prior year.
  • Net cash flow provided by operations of $19.6 million, compared to net cash flow used in operations of $45.3 million in fiscal 2024.
  • GAAP diluted loss per share was $1.58 compared to GAAP diluted loss per share of $2.93 in the prior year, while non-GAAP diluted earnings per share was $0.31 compared to non-GAAP diluted loss per share of $0.90 in fiscal 2024.

Management Commentary

“Our fourth quarter and fiscal year results reflect strong sequential and year-over-year growth in our business,” said Kishore Seendripu, PhD, Chairman and CEO. “Our new products gained solid traction in the market, and we are on a strong path for sustained revenue growth and market share expansion in 2026 and 2027. We are executing against a focused strategy that is working and will drive sustained strong growth even as we continue to invest in high‑value, multi‑year growth markets where performance, power efficiency, and integration matter most. These include data center connectivity, wireless infrastructure, PON broadband access, Wi‑Fi 7, Ethernet, and storage accelerator end markets. With solid execution, we also delivered profitability and positive free cash flow ahead of our plan. During the fourth quarter, we repurchased $20 million of our common stock, reflecting our confidence in our sustained growth expectations and market momentum.”

First Quarter 2026 Business Outlook

The company expects net revenue in the first quarter of 2026 to be approximately $130 million to $140 million. The Company also estimates the following:

  • GAAP gross margin of approximately 56.0% to 59.0%;
  • Non-GAAP gross margin of approximately 58.0% to 61.0%;
  • GAAP operating expenses of approximately $85 million to $90 million;
  • Non-GAAP operating expenses of approximately $58 million to $64 million;
  • GAAP interest and other expense of approximately $2.1 million to $2.7 million;
  • Non-GAAP interest and other expense of approximately $2.0 million to $2.6 million;
  • GAAP income tax provision of $4.0 million and non-GAAP income tax provision of $0.8 million, respectively; and
  • Basic and diluted share count of approximately 88.0 million and 91.0 million, respectively.

Webcast and Conference Call

MaxLinear will host its fourth quarter financial results conference call today, January 29, 2026 at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time). To access this call, dial US toll free: 1-877-407-3109 / International: 1-201-493-6798. A live webcast of the conference call will be accessible from the investor relations section of the MaxLinear website at https://investors.maxlinear.com and will be archived and available after the call at https://investors.maxlinear.com until February 12, 2026. A replay of the conference call will also be available until February 12, 2026 by dialing US toll free: 1-877-660-6853 / International: 1-201-612-7415 and Conference ID#: 13757781.

Cautionary Note Concerning Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Forward-looking statements include, among others, statements concerning our future financial performance (including our current guidance forfirst quarter 2026, including net revenue and GAAP and non-GAAP amounts for each of the following: gross margins, operating expenses, interest and other expenses, income tax provision (benefit), and diluted share counts); our potential growth and expansion, our ability to continue to grow our revenues and profitability; statements regarding our ability to broaden customer traction; statements related to new and increased content opportunities; settlement of bonus awards for our 2025 performance period; statements related to growth trends in the markets in which we operate; and statements by our Chairman and CEO. These forward-looking statements involve known and unknown risks, uncertainties, and other factors that may cause actual results to be materially different from any future results expressed or implied by the forward-looking statements and our future financial performance and operating results forecasts generally. Forward-looking statements are based on management’s current, preliminary expectations and are subject to various risks and uncertainties. In particular, our future operating results are substantially dependent on our assumptions about market trends and conditions. Additional risks and uncertainties affecting our business, future operating results and financial condition include, without limitation, risks relating to: our terminated merger with Silicon Motion and related arbitration and class action complaint and the risks related to potential payment of damages; the effect of intense and increasing competition; increased tariffs, export controls or imposition of other trade barriers; impacts of global economic conditions; the cyclical nature of the semiconductor industry; a significant variance in our operating results and impact on volatility in our stock price, and our ability to sustain our current level of revenue, which has previously declined, and/or manage future growth effectively, and the impact of excess inventory in the channel on our customers’ expected demand for certain of our products and on our revenue; escalating trade wars, military conflicts and other geopolitical and economic tensions among the countries in which we conduct business; international geopolitical and military conflicts; our ability to obtain or retain government authorization to export certain of our products or technology; the loss of, or a significant reduction in orders from major customers; legal proceedings or potential violations of regulations; information technology failures; a decrease in the average selling prices of our products; failure to penetrate new applications and markets; development delays and consolidation trends in our industry; inability to make substantial and productive research and development investments; delays or expenses caused by undetected defects or bugs in our products; substantial quarterly and annual fluctuations in our revenue and operating results; failure to timely develop and introduce new or enhanced products; order and shipment uncertainties and differences between our estimates of customer demand and product mix and our actual results; failure to accurately predict our future revenue and appropriately budget expenses; lengthy and expensive customer qualification processes; customer product plan cancellations; failure to maintain compliance with government regulations; failure to attract and retain qualified personnel; any adverse impact of rising interest rates on us, our customers, and our distributors and related demand; risks related to compliance with privacy, data protection and cybersecurity laws and regulations; risks related to conforming our products to industry standards; risks related to business acquisitions and investments; claims of intellectual property infringement; our ability to protect our intellectual property; security vulnerabilities of our products; use of open source software in our products; failure to manage our relationships with, or negative impacts from, third parties; and future decisions relating to our stock repurchase program.

In addition to these risks and uncertainties, investors should review the risks and uncertainties contained in our filings with the Securities and Exchange Commission (SEC), including our Current Reports on Form 8-K, as well as the information to be set forth under the caption "Risk Factors" in MaxLinear's Annual Report on Form 10-K for the year ended December 31, 2025. All forward-looking statements are based on the estimates, projections and assumptions of management as of January 29, 2026, and MaxLinear is under no obligation (and expressly disclaims any such obligation) to update or revise any forward-looking statements whether as a result of new information, future events, or otherwise.

Use of Non-GAAP Financial Measures

To supplement our unaudited consolidated financial statements presented on a basis consistent with GAAP, we disclose certain non-GAAP financial measures, including, but not limited to, non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating expenses, non-GAAP operating expenses as a percentage of net revenue, non-GAAP income (loss) from operations, non-GAAP income (loss) from operations as percentage of revenue, non-GAAP income (loss) before income taxes, non-GAAP interest and other income (expense), non-GAAP income tax provision, non-GAAP net income (loss), non-GAAP basic and diluted earnings (loss) per share, and non-GAAP diluted share count. These supplemental measures exclude the effects of (i) stock-based compensation expense; (ii) accruals related to our performance-based bonus plan for 2025, which we intend to settle in shares of our common stock; (iii) accruals related to our performance-based bonus plan for 2024, which we settled in shares of common stock in February 2025; (iv) amortization of purchased intangible assets; (v) research and development funded by others; (vi) acquisition and integration costs related to our acquisitions, if any, including costs incurred related to the termination of the previously pending (now terminated) merger with Silicon Motion; (vii) impairment losses; (viii) severance and other restructuring charges; (ix) other non-recurring interest and other income (expenses), net, attributable to acquisitions; and (x) non-cash income tax benefits and expenses. Non-GAAP financial measures are not meant to be considered in isolation or as a substitute for the comparable GAAP financial measures. Non-GAAP financial measures are subject to limitations and should be read only in conjunction with the company’s consolidated financial statements prepared in accordance with GAAP. Non-GAAP financial measures do not have any standardized meaning and are therefore unlikely to be comparable to similarly titled measures presented by other companies. We believe that these non-GAAP measures have limitations in that they do not reflect all of the amounts associated with our GAAP results of operations. We compensate for the limitations of non-GAAP financial measures by relying upon GAAP results to gain a complete picture of our performance.

We believe that non-GAAP financial measures can provide useful information to both management and investors by excluding certain non-cash and other one-time expenses that we believe are not indicative of our core operating results. Among other uses, our management uses non-GAAP measures to compare our performance relative to forecasts and strategic plans and to benchmark our performance externally against competitors. In addition, management’s incentive compensation will be determined in part using these non-GAAP measures because we believe non-GAAP measures better reflect our core operating performance.

The following are explanations of each type of adjustment that we incorporate into non-GAAP financial measures:

Stock-based compensation expense relates to equity incentive awards granted to our employees, directors, and consultants. Our equity incentive plans are important components of our employee incentive compensation arrangements and are reflected as expenses in our GAAP results. Stock-based compensation expense has been and will continue to be a significant recurring expense for MaxLinear. While we include the dilutive impact of equity awards in weighted average shares outstanding, the expense associated with stock-based awards reflects a non-cash charge that we exclude from non-GAAP net income or loss.

Performance-based equity consists of accruals related to our executive and non-executive bonus programs and have been excluded from our non-GAAP net income or loss for all periods reported. Bonus payments for the 2024 performance periods were settled through the issuance of shares of common stock under our equity incentive plans in February 2025. We currently expect that a substantial portion of bonus awards under our fiscal 2025 program will be settled in common stock in the first quarter of fiscal 2026.

Expenses incurred in relation to acquisitions include amortization of purchased intangible assets and acquisition and integration costs primarily consisting of professional and consulting fees, including costs incurred related to the termination of the previously pending (now terminated) merger with Silicon Motion.

Research and development funded by others represents proceeds received under contracts for jointly funded R&D projects to develop technology that may be commercialized into a product in the future. Initially such proceeds may not yet be recognized in GAAP results if, pursuant to contract terms, the Company may be required to repay all or a portion of the funds provided by the other party under certain conditions. Management believes it is not probable that it will trigger such conditions. Once such conditions have been resolved, the proceeds are recognized in GAAP results, and accordingly, reversed from non-GAAP results.

Restructuring charges incurred are related to our restructuring plans which eliminate redundancies and primarily include severance and restructuring costs related to impairment of leased right-of-use assets or from exiting certain facilities and cancellation of contracts.

Other expense includes accretion of discounts on obligations recorded as a result of abandoned leased facilities for which we continue to be obligated to pay but from which we will receive no future benefit.

Income tax benefits and expense adjustments are those that do not affect cash income taxes payable.

Reconciliations of non-GAAP measures for the historic periods disclosed in this press release appear below. Because of the inherent uncertainty associated with our ability to project future charges, we are also unable to predict their probable significance, particularly related to stock-based compensation and its related tax effects as well as potential impairments, a quantitative reconciliation is not available without unreasonable efforts and accordingly, in reliance on the exception provided by Item 10(e)(1)(i)(B) of Regulation S-K, we have not provided a reconciliation for non-GAAP guidance provided for the first quarter 2026.

About MaxLinear, Inc.

MaxLinear, Inc. (Nasdaq:MXL) is a leading provider of radio frequency (RF), analog, digital and mixed-signal integrated circuits for access and connectivity, wired and wireless infrastructure, and industrial and multi-market applications. MaxLinear is headquartered in Carlsbad, California. For more information, please visit www.maxlinear.com.

MXL is MaxLinear’s registered trademark. Other trademarks appearing herein are the property of their respective owners.

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

 

Three Months Ended

 

December 31, 2025

 

September 30, 2025

 

December 31, 2024

Net revenue

$

136,436

 

 

$

126,459

 

 

$

92,167

 

Cost of net revenue

 

57,879

 

 

 

54,558

 

 

 

40,919

 

Gross profit

 

78,557

 

 

 

71,901

 

 

 

51,248

 

Operating expenses:

 

 

 

 

 

Research and development

 

51,691

 

 

 

54,252

 

 

 

51,278

 

Selling, general and administrative

 

41,956

 

 

 

47,674

 

 

 

38,087

 

Restructuring charges (credits)

 

(198

)

 

 

11,264

 

 

 

3,056

 

Total operating expenses

 

93,449

 

 

 

113,190

 

 

 

92,421

 

Loss from operations

 

(14,892

)

 

 

(41,289

)

 

 

(41,173

)

Interest income

 

835

 

 

 

874

 

 

 

1,040

 

Interest expense

 

(2,391

)

 

 

(2,649

)

 

 

(2,802

)

Other income (expense), net

 

(1,355

)

 

 

(324

)

 

 

2,113

 

Total other income (expense), net

 

(2,911

)

 

 

(2,099

)

 

 

351

 

Loss before income taxes

 

(17,803

)

 

 

(43,388

)

 

 

(40,822

)

Income tax provision (benefit)

 

(2,906

)

 

 

2,097

 

 

 

17,016

 

Net loss

$

(14,897

)

 

$

(45,485

)

 

$

(57,838

)

Net loss per share:

 

 

 

 

 

Basic

$

(0.17

)

 

$

(0.52

)

 

$

(0.68

)

Diluted

$

(0.17

)

 

$

(0.52

)

 

$

(0.68

)

Shares used to compute net loss per share:

 

 

 

 

 

Basic

 

87,243

 

 

 

87,186

 

 

 

84,485

 

Diluted

 

87,243

 

 

 

87,186

 

 

 

84,485

 

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

 

 

 

 

 

 

 

Twelve Months Ended

 

 

December 31, 2025

 

December 31, 2024

Net revenue

 

$

467,641

 

 

$

360,528

 

Cost of net revenue

 

 

201,827

 

 

 

165,746

 

Gross profit

 

 

265,814

 

 

 

194,782

 

Operating expenses:

 

 

 

 

Research and development

 

 

208,599

 

 

 

225,189

 

Selling, general and administrative

 

 

159,580

 

 

 

138,329

 

Impairment losses

 

 

 

 

 

1,237

 

Restructuring charges

 

 

24,525

 

 

 

53,379

 

Total operating expenses

 

 

392,704

 

 

 

418,134

 

Loss from operations

 

 

(126,890

)

 

 

(223,352

)

Interest income

 

 

3,385

 

 

 

6,386

 

Interest expense

 

 

(10,056

)

 

 

(10,874

)

Other income (expense), net

 

 

(7,333

)

 

 

(10,877

)

Total other income (expense), net

 

 

(14,004

)

 

 

(15,365

)

Loss before income taxes

 

 

(140,894

)

 

 

(238,717

)

Income tax provision (benefit)

 

 

(4,213

)

 

 

6,481

 

Net loss

 

$

(136,681

)

 

$

(245,198

)

Net loss per share:

 

 

 

 

Basic

 

$

(1.58

)

 

$

(2.93

)

Diluted

 

$

(1.58

)

 

$

(2.93

)

Shares used to compute net loss per share:

 

 

 

 

Basic

 

 

86,588

 

 

 

83,600

 

Diluted

 

 

86,588

 

 

 

83,600

 

 

 

 

 

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

Three Months Ended

 

December 31, 2025

 

September 30, 2025

 

December 31, 2024

Operating Activities

 

 

 

 

 

Net loss

$

(14,897

)

 

$

(45,485

)

 

$

(57,838

)

Adjustments to reconcile net loss to cash provided by (used in) operating activities:

 

 

 

 

 

Amortization and depreciation

 

10,788

 

 

 

10,838

 

 

 

11,714

 

Impairment of other assets

 

700

 

 

 

 

 

 

 

Amortization of debt issuance costs and accretion of discount on debt and leases

 

451

 

 

 

477

 

 

 

548

 

Stock-based compensation

 

19,593

 

 

 

21,511

 

 

 

18,813

 

Deferred income taxes

 

(2,515

)

 

 

275

 

 

 

13,884

 

Loss on disposal of property and equipment

 

86

 

 

 

261

 

 

 

 

Impairment of leased right-of-use assets

 

 

 

 

 

 

 

2,140

 

Gain on extinguishment of lease liabilities

 

(521

)

 

 

 

 

 

(1

)

(Gain) loss on foreign currency and other

 

487

 

 

 

211

 

 

 

(2,226

)

Excess tax (benefits) deficiencies on stock-based awards

 

(492

)

 

 

1,931

 

 

 

262

 

Changes in operating assets and liabilities:

 

 

 

 

 

Accounts receivable, net

 

6,812

 

 

 

52,884

 

 

 

(37,534

)

Inventory

 

8,225

 

 

 

(298

)

 

 

5,720

 

Prepaid expenses and other assets

 

(17,527

)

 

 

1,173

 

 

 

6,742

 

Accounts payable, accrued expenses and other current liabilities

 

3,062

 

 

 

(40,139

)

 

 

17,448

 

Accrued compensation

 

7,866

 

 

 

15,047

 

 

 

(2,092

)

Accrued price protection liability

 

(7,346

)

 

 

(5,681

)

 

 

(1,071

)

Lease liabilities

 

(2,792

)

 

 

(2,928

)

 

 

(2,889

)

Other long-term liabilities

 

(1,574

)

 

 

47

 

 

 

(1,458

)

Net cash provided by (used in) operating activities

 

10,406

 

 

 

10,124

 

 

 

(27,838

)

Investing Activities

 

 

 

 

 

Purchases of property and equipment

 

(3,708

)

 

 

(5,729

)

 

 

(2,193

)

Purchases of intangible assets

 

22

 

 

 

(1,012

)

 

 

(805

)

Net cash used in investing activities

 

(3,686

)

 

 

(6,741

)

 

 

(2,998

)

Financing Activities

 

 

 

 

 

Net proceeds from issuance of common stock

 

1,391

 

 

 

27

 

 

 

2,512

 

Minimum tax withholding paid on behalf of employees for restricted stock units

 

(4

)

 

 

(12

)

 

 

(1,091

)

Repurchase of common stock

 

(20,000

)

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

(18,613

)

 

 

15

 

 

 

1,421

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

42

 

 

 

(388

)

 

 

(474

)

Increase (decrease) in cash, cash equivalents and restricted cash

 

(11,851

)

 

 

3,010

 

 

 

(29,889

)

Cash, cash equivalents and restricted cash at beginning of period

 

113,263

 

 

 

110,253

 

 

 

149,492

 

Cash, cash equivalents and restricted cash at end of period

$

101,412

 

 

$

113,263

 

 

$

119,603

 

 

 

 

 

 

 

MAXLINEAR, INC.

UNAUDITED GAAP CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

 

 

 

 

 

 

Twelve Months Ended

 

 

December 31, 2025

 

December 31, 2024

Operating Activities

 

 

 

 

Net loss

 

$

(136,681

)

 

$

(245,198

)

Adjustments to reconcile net loss to cash provided by (used in) operating activities:

 

 

 

 

Amortization and depreciation

 

 

43,992

 

 

 

54,140

 

Impairment of intangible assets

 

 

 

 

 

1,237

 

Impairment of investments and other assets

 

 

700

 

 

 

14,000

 

Amortization of debt issuance costs and accretion of discount on debt and leases

 

 

1,929

 

 

 

2,538

 

Stock-based compensation

 

 

77,128

 

 

 

66,021

 

Deferred income taxes

 

 

(8,595

)

 

 

826

 

Loss on disposal of property and equipment

 

 

1,247

 

 

 

1,068

 

Impairment of leased right-of-use assets

 

 

427

 

 

 

5,555

 

Gain on extinguishment of lease liabilities

 

 

(521

)

 

 

(555

)

Gain (loss) on foreign currency and other

 

 

6,159

 

 

 

(1,253

)

Excess tax deficiencies on stock-based awards

 

 

3,713

 

 

 

3,250

 

Changes in operating assets and liabilities:

 

 

 

 

Accounts receivable, net

 

 

39,342

 

 

 

85,155

 

Inventory

 

 

12,239

 

 

 

9,565

 

Prepaid expenses and other assets

 

 

(11,874

)

 

 

(1,873

)

Accounts payable, accrued expenses and other current liabilities

 

 

(12,484

)

 

 

(4,569

)

Accrued compensation

 

 

34,762

 

 

 

919

 

Accrued price protection liability

 

 

(16,908

)

 

 

(28,283

)

Lease liabilities

 

 

(11,497

)

 

 

(10,695

)

Other long-term liabilities

 

 

(3,459

)

 

 

2,857

 

Net cash provided by (used in) operating activities

 

 

19,619

 

 

 

(45,295

)

Investing Activities

 

 

 

 

Purchases of property and equipment

 

 

(12,598

)

 

 

(17,680

)

Purchases of intangible assets

 

 

(7,197

)

 

 

(5,766

)

Net cash used in investing activities

 

 

(19,795

)

 

 

(23,446

)

Financing Activities

 

 

 

 

Net proceeds from issuance of common stock

 

 

3,558

 

 

 

4,091

 

Minimum tax withholding paid on behalf of employees for restricted stock units

 

 

(2,217

)

 

 

(2,805

)

Repurchase of common stock

 

 

(20,000

)

 

 

 

Net cash provided by (used in) financing activities

 

 

(18,659

)

 

 

1,286

 

Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 

644

 

 

 

(1,298

)

Decrease in cash, cash equivalents and restricted cash

 

 

(18,191

)

 

 

(68,753

)

Cash, cash equivalents and restricted cash at beginning of period

 

 

119,603

 

 

 

188,356

 

Cash, cash equivalents and restricted cash at end of period

 

$

101,412

 

 

$

119,603

 

 

 

 

 

 

 

 

 

 

 

MAXLINEAR, INC.

UNAUDITED GAAP CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands)

 

 

December 31, 2025

 

September 30, 2025

 

December 31, 2024

Assets

 

 

 

 

 

Current assets:

 

 

 

 

 

Cash and cash equivalents

$

72,806

 

$

111,859

 

$

118,575

Short-term restricted cash

 

1,419

 

 

1,380

 

 

1,003

Accounts receivable, net

 

46,122

 

 

52,934

 

 

85,464

Inventory

 

78,104

 

 

86,329

 

 

90,343

Prepaid expenses and other current assets

 

50,390

 

 

31,630

 

 

28,057

Total current assets

 

248,841

 

 

284,132

 

 

323,442

Long-term restricted cash

 

27,187

 

 

24

 

 

25

Property and equipment, net

 

48,873

 

 

50,865

 

 

59,300

Leased right-of-use assets

 

15,506

 

 

14,624

 

 

18,184

Intangible assets, net

 

48,892

 

 

52,066

 

 

55,008

Goodwill

 

318,588

 

 

318,588

 

 

318,588

Deferred tax assets

 

77,268

 

 

74,764

 

 

68,662

Other long-term assets

 

11,241

 

 

13,070

 

 

21,430

Total assets

$

796,396

 

$

808,133

 

$

864,639

 

 

 

 

 

 

Liabilities and stockholders’ equity

 

 

 

 

 

Current liabilities

$

186,020

 

$

183,551

 

$

182,284

Long-term lease liabilities

 

12,313

 

 

12,133

 

 

16,952

Long-term debt

 

123,618

 

 

123,461

 

 

122,996

Other long-term liabilities

 

22,550

 

 

24,261

 

 

26,124

Stockholders’ equity

 

451,895

 

 

464,727

 

 

516,283

Total liabilities and stockholders’ equity

$

796,396

 

$

808,133

 

$

864,639

 

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

(in thousands, except per share data)

 

 

Three Months Ended

 

December 31, 2025

 

September 30, 2025

 

December 31, 2024

GAAP gross profit

$

78,557

 

 

$

71,901

 

 

$

51,248

 

Stock-based compensation

 

121

 

 

 

164

 

 

 

186

 

Performance-based equity

 

84

 

 

 

136

 

 

 

8

 

Amortization of purchased intangible assets

 

2,583

 

 

 

2,582

 

 

 

2,990

 

Non-GAAP gross profit

 

81,345

 

 

 

74,783

 

 

 

54,432

 

 

 

 

 

 

 

GAAP R&D expenses

 

51,691

 

 

 

54,252

 

 

 

51,278

 

Stock-based compensation

 

(9,443

)

 

 

(9,750

)

 

 

(10,862

)

Performance-based equity

 

(5,148

)

 

 

(7,361

)

 

 

(743

)

Non-GAAP R&D expenses

 

37,100

 

 

 

37,141

 

 

 

39,673

 

 

 

 

 

 

 

GAAP SG&A expenses

 

41,956

 

 

 

47,674

 

 

 

38,087

 

Stock-based compensation

 

(10,030

)

 

 

(11,597

)

 

 

(7,766

)

Performance-based equity

 

(3,512

)

 

 

(3,750

)

 

 

(811

)

Amortization of purchased intangible assets

 

(206

)

 

 

(350

)

 

 

(592

)

Acquisition and integration costs

 

(6,093

)

 

 

(9,572

)

 

 

(7,261

)

Non-GAAP SG&A expenses

 

22,115

 

 

 

22,405

 

 

 

21,657

 

 

 

 

 

 

 

GAAP restructuring expenses (credits)

 

(198

)

 

 

11,264

 

 

 

3,056

 

Restructuring charges

 

198

 

 

 

(11,264

)

 

 

(3,056

)

Non-GAAP restructuring expenses

 

 

 

 

 

 

 

 

 

 

 

 

 

 

GAAP loss from operations

 

(14,892

)

 

 

(41,289

)

 

 

(41,173

)

Total non-GAAP adjustments

 

37,022

 

 

 

56,526

 

 

 

34,275

 

Non-GAAP income (loss) from operations

 

22,130

 

 

 

15,237

 

 

 

(6,898

)

 

 

 

 

 

 

GAAP interest and other income (expense), net

 

(2,911

)

 

 

(2,099

)

 

 

351

 

Non-recurring interest and other income (expense), net

 

146

 

 

 

298

 

 

 

326

 

Non-GAAP interest and other income (expense), net

 

(2,765

)

 

 

(1,801

)

 

 

677

 

 

 

 

 

 

 

GAAP loss before income taxes

 

(17,803

)

 

 

(43,388

)

 

 

(40,822

)

Total non-GAAP adjustments

 

37,168

 

 

 

56,824

 

 

 

34,601

 

Non-GAAP income (loss) before income taxes

 

19,365

 

 

 

13,436

 

 

 

(6,221

)

 

 

 

 

 

 

GAAP income tax provision (benefit)

 

(2,906

)

 

 

2,097

 

 

 

17,016

 

Adjustment for non-cash tax benefits/expenses

 

4,906

 

 

 

(797

)

 

 

(16,016

)

Non-GAAP income tax provision

 

2,000

 

 

 

1,300

 

 

 

1,000

 

 

 

 

 

 

 

GAAP net loss

 

(14,897

)

 

 

(45,485

)

 

 

(57,838

)

Total non-GAAP adjustments before income taxes

 

37,168

 

 

 

56,824

 

 

 

34,601

 

Less: total tax adjustments

 

4,906

 

 

 

(797

)

 

 

(16,016

)

Non-GAAP net income (loss)

$

17,365

 

 

$

12,136

 

 

$

(7,221

)

 

 

 

 

 

 

Shares used in computing GAAP and non-GAAP basic net income (loss) per share

 

87,243

 

 

 

87,186

 

 

 

84,485

 

Shares used in computing GAAP diluted net loss per share

 

87,243

 

 

 

87,186

 

 

 

84,485

 

Dilutive common stock equivalents

 

3,399

 

 

 

671

 

 

 

 

Shares used in computing non-GAAP diluted net income (loss) per share

 

90,642

 

 

 

87,857

 

 

 

84,485

 

Non-GAAP basic net income (loss) per share

$

0.20

 

 

$

0.14

 

 

$

(0.09

)

Non-GAAP diluted net income (loss) per share

$

0.19

 

 

$

0.14

 

 

$

(0.09

)

 

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF NON-GAAP ADJUSTMENTS

(in thousands, except per share data)

 

 

 

 

 

Twelve Months Ended

 

December 31, 2025

 

December 31, 2024

GAAP gross profit

$

265,814

 

 

$

194,782

 

Stock-based compensation

 

722

 

 

 

621

 

Performance-based equity

 

331

 

 

 

24

 

Amortization of purchased intangible assets

 

10,329

 

 

 

19,798

 

Non-GAAP gross profit

 

277,196

 

 

 

215,225

 

 

 

 

 

GAAP R&D expenses

 

208,599

 

 

 

225,189

 

Stock-based compensation

 

(41,474

)

 

 

(38,814

)

Performance-based equity

 

(20,833

)

 

 

(3,108

)

Research and development funded by others

 

(1,000

)

 

 

2,000

 

Non-GAAP R&D expenses

 

145,292

 

 

 

185,267

 

 

 

 

 

GAAP SG&A expenses

 

159,580

 

 

 

138,329

 

Stock-based compensation

 

(34,933

)

 

 

(26,586

)

Performance-based equity

 

(11,546

)

 

 

(2,132

)

Amortization of purchased intangible assets

 

(1,739

)

 

 

(2,366

)

Acquisition and integration costs

 

(22,953

)

 

 

(8,828

)

Non-GAAP SG&A expenses

 

88,409

 

 

 

98,417

 

 

 

 

 

GAAP impairment losses

 

 

 

 

1,237

 

Impairment losses

 

 

 

 

(1,237

)

Non-GAAP impairment losses

 

 

 

 

 

 

 

 

 

GAAP restructuring expenses

 

24,525

 

 

 

53,379

 

Restructuring charges

 

(24,525

)

 

 

(53,379

)

Non-GAAP restructuring expenses

 

 

 

 

 

 

 

 

 

GAAP loss from operations

 

(126,890

)

 

 

(223,352

)

Total non-GAAP adjustments

 

170,385

 

 

 

154,893

 

Non-GAAP income (loss) from operations

 

43,495

 

 

 

(68,459

)

 

 

 

 

GAAP interest and other income (expense), net

 

(14,004

)

 

 

(15,365

)

Non-recurring interest and other income (expense), net

 

835

 

 

 

12,233

 

Non-GAAP interest and other income (expense), net

 

(13,169

)

 

 

(3,132

)

 

 

 

 

GAAP loss before income taxes

 

(140,894

)

 

 

(238,717

)

Total non-GAAP adjustments

 

171,220

 

 

 

167,126

 

Non-GAAP income (loss) before income taxes

 

30,326

 

 

 

(71,591

)

 

 

 

 

GAAP income tax provision (benefit)

 

(4,213

)

 

 

6,481

 

Adjustment for non-cash tax benefits/expenses

 

7,653

 

 

 

(2,481

)

Non-GAAP income tax provision

 

3,440

 

 

 

4,000

 

 

 

 

 

GAAP net loss

 

(136,681

)

 

 

(245,198

)

Total non-GAAP adjustments before income taxes

 

171,220

 

 

 

167,126

 

Less: total tax adjustments

 

7,653

 

 

 

(2,481

)

Non-GAAP net income (loss)

$

26,886

 

 

$

(75,591

)

 

 

 

 

Shares used in computing GAAP and non-GAAP basic net income (loss) per share

 

86,588

 

 

 

83,600

 

Shares used in computing GAAP diluted net loss per share

 

86,588

 

 

 

83,600

 

Dilutive common stock equivalents

 

1,300

 

 

 

 

Shares used in computing non-GAAP diluted net income (loss) per share

 

87,888

 

 

 

83,600

 

Non-GAAP basic net income (loss) per share

$

0.31

 

 

$

(0.90

)

Non-GAAP diluted net income (loss) per share

$

0.31

 

 

$

(0.90

)

 

 

 

 

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
AS A PERCENTAGE OF NET REVENUE

 

 

Three Months Ended

 

December 31, 2025

 

September 30, 2025

 

December 31, 2024

GAAP gross margin

57.6

%

 

56.9

%

 

55.6

%

Stock-based compensation

0.1

%

 

0.1

%

 

0.2

%

Performance-based equity

0.1

%

 

0.1

%

 

%

Amortization of purchased intangible assets

1.9

%

 

2.0

%

 

3.2

%

Non-GAAP gross margin

59.6

%

 

59.1

%

 

59.1

%

 

 

 

 

 

 

GAAP R&D expenses

37.9

%

 

42.9

%

 

55.6

%

Stock-based compensation

(6.9

)%

 

(7.7

)%

 

(11.8

)%

Performance-based equity

(3.8

)%

 

(5.8

)%

 

(0.8

)%

Non-GAAP R&D expenses

27.2

%

 

29.4

%

 

43.0

%

 

 

 

 

 

 

GAAP SG&A expenses

30.8

%

 

37.7

%

 

41.3

%

Stock-based compensation

(7.4

)%

 

(9.2

)%

 

(8.4

)%

Performance-based equity

(2.6

)%

 

(3.0

)%

 

(0.9

)%

Amortization of purchased intangible assets

(0.2

)%

 

(0.3

)%

 

(0.6

)%

Acquisition and integration costs

(4.5

)%

 

(7.6

)%

 

(7.9

)%

Non-GAAP SG&A expenses

16.2

%

 

17.7

%

 

23.5

%

 

 

 

 

 

 

GAAP restructuring expenses (credits)

(0.2

)%

 

8.9

%

 

3.3

%

Restructuring charges

0.2

%

 

(8.9

)%

 

(3.3

)%

Non-GAAP restructuring expenses

%

 

%

 

%

 

 

 

 

 

 

GAAP loss from operations

(10.9

)%

 

(32.7

)%

 

(44.7

)%

Total non-GAAP adjustments

27.1

%

 

44.7

%

 

37.2

%

Non-GAAP income (loss) from operations

16.2

%

 

12.1

%

 

(7.5

)%

 

 

 

 

 

 

GAAP interest and other income (expense), net

(2.1

)%

 

(1.7

)%

 

0.4

%

Non-recurring interest and other income (expense), net

0.1

%

 

0.2

%

 

0.4

%

Non-GAAP interest and other income (expense), net

(2.0

)%

 

(1.4

)%

 

0.7

%

 

 

 

 

 

 

GAAP loss before income taxes

(13.1

)%

 

(34.3

)%

 

(44.3

)%

Total non-GAAP adjustments

27.2

%

 

44.9

%

 

37.5

%

Non-GAAP income (loss) before income taxes

14.2

%

 

10.6

%

 

(6.8

)%

 

 

 

 

 

 

GAAP income tax provision (benefit)

(2.1

)%

 

1.7

%

 

18.5

%

Adjustment for non-cash tax benefits/expenses

3.6

%

 

(0.6

)%

 

(17.4

)%

Non-GAAP income tax provision

1.5

%

 

1.0

%

 

1.1

%

 

 

 

 

 

 

GAAP net loss

(10.9

)%

 

(36.0

)%

 

(62.8

)%

Total non-GAAP adjustments before income taxes

27.2

%

 

44.9

%

 

37.5

%

Less: total tax adjustments

3.6

%

 

(0.6

)%

 

(17.4

)%

Non-GAAP net income (loss)

12.7

%

 

9.6

%

 

(7.8

)%

 

MAXLINEAR, INC.

UNAUDITED RECONCILIATION OF GAAP TO NON-GAAP FINANCIAL MEASURES
AS A PERCENTAGE OF NET REVENUE

 

 

 

 

 

Twelve Months Ended

 

December 31, 2025

 

December 31, 2024

GAAP gross margin

56.8

%

 

54.0

%

Stock-based compensation

0.2

%

 

0.2

%

Performance-based equity

0.1

%

 

%

Amortization of purchased intangible assets

2.2

%

 

5.5

%

Non-GAAP gross margin

59.3

%

 

59.7

%

 

 

 

 

GAAP R&D expenses

44.6

%

 

62.5

%

Stock-based compensation

(8.9

)%

 

(10.8

)%

Performance-based equity

(4.5

)%

 

(0.9

)%

Research and development funded by others

(0.2

)%

 

0.6

%

Non-GAAP R&D expenses

31.1

%

 

51.4

%

 

 

 

 

GAAP SG&A expenses

34.1

%

 

38.4

%

Stock-based compensation

(7.5

)%

 

(7.4

)%

Performance-based equity

(2.5

)%

 

(0.6

)%

Amortization of purchased intangible assets

(0.4

)%

 

(0.7

)%

Acquisition and integration costs

(4.9

)%

 

(2.5

)%

Non-GAAP SG&A expenses

18.9

%

 

27.3

%

 

 

 

 

GAAP impairment losses

%

 

0.3

%

Impairment losses

%

 

(0.3

)%

Non-GAAP impairment losses

%

 

%

 

 

 

 

GAAP restructuring expenses

5.2

%

 

14.8

%

Restructuring charges

(5.2

)%

 

(14.8

)%

Non-GAAP restructuring expenses

%

 

%

 

 

 

 

GAAP loss from operations

(27.1

)%

 

(62.0

)%

Total non-GAAP adjustments

36.4

%

 

43.0

%

Non-GAAP income (loss) from operations

9.3

%

 

(19.0

)%

 

 

 

 

GAAP interest and other income (expense), net

(3.0

)%

 

(4.3

)%

Non-recurring interest and other income (expense), net

0.2

%

 

3.4

%

Non-GAAP interest and other income (expense), net

(2.8

)%

 

(0.9

)%

 

 

 

 

GAAP loss before income taxes

(30.1

)%

 

(66.2

)%

Total non-GAAP adjustments

36.6

%

 

46.4

%

Non-GAAP income (loss) before income taxes

6.5

%

 

(19.9

)%

 

 

 

 

GAAP income tax provision (benefit)

(0.9

)%

 

1.8

%

Adjustment for non-cash tax benefits/expenses

1.6

%

 

(0.7

)%

Non-GAAP income tax provision

0.7

%

 

1.1

%

 

 

 

 

GAAP net loss

(29.2

)%

 

(68.0

)%

Total non-GAAP adjustments before income taxes

36.6

%

 

46.4

%

Less: total tax adjustments

1.6

%

 

(0.7

)%

Non-GAAP net income (loss)

5.8

%

 

(21.0

)%

 

View source version on businesswire.com:https://www.businesswire.com/news/home/20260129589719/en/

CONTACT: MaxLinear, Inc. Investor Relations Contact:

Leslie Green

[email protected]

KEYWORD: CALIFORNIA UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: NETWORKS SEMICONDUCTOR HARDWARE MOBILE/WIRELESS TECHNOLOGY

SOURCE: MaxLinear, Inc.

Copyright Business Wire 2026.

PUB: 01/29/2026 04:05 PM/DISC: 01/29/2026 04:05 PM

http://www.businesswire.com/news/home/20260129589719/en

 

Salem News Channel Today

Sponsored Links

On Air & Up Next

  • The American Adversaries with Christopher Hart and Company
     
    The Titans of Talk Radio The Voice to be Reckoned With “Political, Professional   >>
     
  • Healthcare Now with Larry Jones and Mark Chaet
     
    The “truth about U.S. healthcare” is the most important issue today. Healthcare   >>
     
  • The Larry Elder Show
    8:00PM - 10:00PM
     
    Larry Elder personifies the phrase “We’ve Got a Country to Save” The “Sage from   >>
     
  • The Scott Jennings Show
    10:00PM - 12:00AM
     
    Jennings is battle-tested on cable news, a veteran of four presidential   >>
     
  • The Mike Gallagher Show
    12:00AM - 3:00AM
     
    FBI executes search warrant seeking ballots from Fulton County’s 2020 election   >>
     

See the Full Program Guide